title: Ablation for the management of pulmonary malignancies.
abstract: OBJECTIVE
  Surgical resection remains the treatment of choice for patients with early-stage primary lung cancer and selected patients with limited metastatic lung disease. However, surgery is a high-risk treatment for patients with coexisting morbidities, severe chronic obstructive pulmonary disease, a single lung, or a history of prior resection. The indications for and outcomes of ablative therapies performed for the management of pulmonary malignancies are discussed.
  
  
  CONCLUSIONS
  Preservation of residual lung parenchyma when treating patients with early-stage primary lung cancer and those with limited metastatic lung disease is vital and can be achieved with image-guided thermal ablation therapies.
authors.affiliation: Department of Interventional Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Rm H118, New York, NY 10065, USA. sofoclec@mskcc.org
authors.forename: Constantinos T
authors.initials: CT
authors.lastname: Sofocleous
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Sideras
authors.forename: Elena N
authors.initials: EN
authors.lastname: Petre
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Solomon
mesh_terms: D017115:Catheter Ablation / Q000379:methods*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000556:secondary / Q000601:surgery*; D009367:Neoplasm Staging; D010347:Patient Care Planning; D049268:Positron-Emission Tomography; D011183:Postoperative Complications; D015641:Radiography, Interventional / Q000379:methods*; D014057:Tomography, X-Ray Computed